Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

Gut

Volumn 38, Issue 4, 1996, Pages 610-615

  Broome U ^a   Olsson, R ^b   Loof L ^c   Bodemar, G ^d   Hultcrantz, R ^a   Danielsson, A ^e   Prytz, H ^f   Sandberg Gertzen H ^g   Wallerstedt, S ^b   Lindberg, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholangiocarcinoma; Liver transplantation; Prognostic models; Ulcerative colitis

Indexed keywords

BILIRUBIN;

ARTICLE; DISEASE COURSE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SWEDEN;

EID: 9244260186     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.4.610     Document Type: Article

References (26)

1. Chapman RW, Burroughs AK, Bass NM, Sherlock S. Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci 1981; 26: 778-82.
2. Rosen CB, Nagorney DM, Wiesner RH, Coffey R Jr, La Russo NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-5.
3. Marsh J Jr, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988; 207: 212-5.
4. Krom RAF, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE, et al. The first 100 liver transplantations at the Mayo Clinic. Proc Mayo Clin 1989; 64: 89-94.
5. Langnas AN, Grazi GL, Stratta RJ, Wood RP, Marujo W, Markin RS, et al. Primacy sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990; 85: 1136-41.
6. Wiesner RH, Porayko MK, Dickson ER, Gores GJ, La Russo NF, Hay JE, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992; 16: 1290-9.
7. Heltzberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987; 92: 1869-75.
8. Wiesner RH, Grambsch PM, Dickson R, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
9. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-7.
10. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893-901.
11. Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis; a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870-7.
12. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-6.
13. Ludwig J, Barham SS, La Russo NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1: 632-40.
14. Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965; 6: 311-24.
15. Farmer RG, Mawic WA, Turnbull RR. Clinical patterns in Crohn's disease: a statistical study of 6155 cases. Gastroenterology 1975; 68: 627-35.
16. Olsson R, Danielsson Å, Järnerot G, Lindström E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319-23.
17. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987; 22: 655-64.
18. Broomé U, Glaumann H, Hellers G, Sörstad J, Nilsson B, Hultcrantz R. Liver disease in ulcerative colitis. An epidemiological and follow-up study in the county of Stockholm. Gut 1994; 35: 84-9.
19. Bromé U, Ljusk Eriksson S. Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1994; 20: 654-9.
20. Miros M, Kerlin P, Walker N. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gut 1991; 32: 1369-73.
21. Christianssen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time dependent cox regression model. Gastroenterology 1993; 105: 1865-76.
22. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990; 322: 1842-4.
23. Zetterquist H, Broomé U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 1992; 33: 942-6.
24. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129-33.
25. Olerup O, Olsson R, Hultcrantz R, Broomé U. HLA-DR and DQ alleles are not markers for rapid disease progression in Swedish patients with primary sclerosing cholangitis. Gastroenterology 1995; 108: 870-8.
26. Mehal WZ, Lo YMD, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106: 160-7.